Literature DB >> 20182311

Meta-analysis of randomized trials: evaluation of benefit of gemcitabine-based molecular targeted therapy for inoperable pancreatic cancer.

Yunfei Cao, Liucheng Wu, Aihua Tan, Lidan Liu, Cun Liao, Feng Gao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20182311     DOI： 10.1097/MPA.0b013e3181bdc6b8

Source DB:  PubMed          Journal:  Pancreas        ISSN： 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  1 in total

1.  Outcome of gemcitabine plus molecular targeted agent for treatment of pancreatic cancer: a meta-analysis of prospective phase III studies.

Authors:  Lin Chen; Ming Zhang; Shuchun Luo
Journal:  Tumour Biol       Date:  2014-08-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.